Received: from mail1.rit.ee (213.184.53.4) by
 AMS1EPF0000004B.mail.protection.outlook.com (10.167.16.136) with Microsoft
 SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.270.5
 via Frontend Transport; Tue, 28 Jul 2026 10:07:45 +0000
Received: from AMS1EPF0000004B.eurprd04.prod.outlook.com
 (2603:10a6:20b:657:cafe::8a) by AS4P191CA0042.outlook.office365.com
 (2603:10a6:20b:657::19) with Microsoft SMTP Server (version=TLS1_3,
 cipher=TLS_AES_256_GCM_SHA384) id 15.21.270.12 via Frontend Transport; Tue,
 28 Jul 2026 10:07:46 +0000
Received: from sp-exc-1703.welcome.ec.europa.eu (10.152.64.163) by
 sp-exc-ed112.rcnet.cec.eu.int (147.67.249.4) with Microsoft SMTP Server
 (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id
 15.2.2562.45; Tue, 28 Jul 2026 12:07:42 +0200
Received: from sp-exc-1703.welcome.ec.europa.eu ([10.152.64.163]) by
 sp-exc-1703.welcome.ec.europa.eu ([10.152.64.163]) with mapi id
 15.02.2562.045; Tue, 28 Jul 2026 12:07:41 +0200
Received: from sp-exc-1703.welcome.ec.europa.eu (10.152.64.163) by
 sp-exc-1703.welcome.ec.europa.eu (10.152.64.163) with Microsoft SMTP Server
 (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id
 15.2.2562.45; Tue, 28 Jul 2026 12:07:41 +0200
Received: from BESPR02MB12392.eurprd02.prod.outlook.com
 (2603:10a6:b10:101::21) by DB9PR02MB7817.eurprd02.prod.outlook.com with
 HTTPS; Tue, 28 Jul 2026 10:07:48 +0000
Received: from AS4P191CA0042.EURP191.PROD.OUTLOOK.COM (2603:10a6:20b:657::19)
 by BESPR02MB12392.eurprd02.prod.outlook.com (2603:10a6:b10:101::21) with
 Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.270.12; Tue, 28 Jul
 2026 10:07:46 +0000
From: <SANTE-SOHO@ec.europa.eu>
To: <SANTE-SOHO@ec.europa.eu>
Cc: <sophie.lucas-samuel@biomedecine.fr>,
	"CLAUS Mirko" <Mirko.CLAUS@ec.europa.eu>,
	"Jo Wiersum" <j.wiersum@tripnet.nl>,
	<sixtine.drougard@ansm.sante.fr>,
	<Melissa.Pontari@ms.etat.lu>
Subject: =?utf-8?Q?Survey_on_epidemiological_notice?=
	=?utf-8?Q?s_in_RAB/RATC_platforms_=E2=80=93_deadli?=
	=?utf-8?Q?ne_28_August_2026?=
Date: Tue, 28 Jul 2026 13:07:41 +0300
Keywords: Mall
Message-ID: <5cc41e5edb2a4db59eb6be3e864e6aef@ec.europa.eu>
MIME-Version: 1.0
Content-Type: multipart/related;
	boundary="----=_NextPart_000_0070_01DD1F5F.3D26F3A0"
X-Mailer: Microsoft Outlook 16.0
Thread-Index: AQLC/AQm3RKjmNLocTd3CVmIL4RY7A==
Authentication-Results: spf=fail (sender IP is 213.184.53.4)
 smtp.mailfrom=ec.europa.eu; dkim=pass (signature was verified)
 header.d=ec.europa.eu;dmarc=pass action=none
 header.from=ec.europa.eu;compauth=pass reason=100
X-CSE-ConnectionGUID: yA9FBhtOSKixamOsqJDmyQ==
X-CSE-MsgGUID: aeYsXE4nTJyTYT6WJMeeQw==
X-ThreatScanner-Verdict: Negative
X-IPAS-Result: =?us-ascii?q?A0ECAADQfmhqfAT5Q5NaGgEBAQEBAQEBAQEDAQEBARIBA?=
 =?us-ascii?q?QEBAgIBAQEBgXwFAQEBAQsBgTyBBIEKgRIHIQEBLh2EO4gbiViSHowAFIErP?=
 =?us-ascii?q?QIIBwEBAQEBAQcBAwFEDQQBAQMEhDhGAhaNTiEGATQJDgECAwEDAgMBAQEBA?=
 =?us-ascii?q?QEBAQEBAQsBAQEEAQEBAgEBAgQDAQEBAQIQAQE7Bw4SKYZPAQyCYoElZQk4A?=
 =?us-ascii?q?QEBAQEBAQEBAQEBAQEBAQEBARYCH20BAQIGARILAggBEgEBEhUBCAcBBA0BJ?=
 =?us-ascii?q?QEBAQoVAwIEBQ8BDAIMFAYMAQQOBAEGAgaCdYIpJCcUwRJ6gTKBATuBUQEBB?=
 =?us-ascii?q?gQDAgPcPIFJCQMGCQGBQwGITg0BKhGBIgIBAg5aggOBGg8BOIIVgTV6gQEBg?=
 =?us-ascii?q?QlEgRU1hDlNgjdnCYMlgmqCJnoShQyBXotYLGADCQYCAgIPLQYDWSwBD0YTF?=
 =?us-ascii?q?wsHBYFmAyovLW4iEB2BIz4LDAgsWBsHBYEdMHxhhFgjGTl/gTF1SnctaQESF?=
 =?us-ascii?q?4EagzwCgUxJAwsHZj03FBkGAYE1CBYEFgkFBAMJBgICBTiJeRAhDYE6OSkig?=
 =?us-ascii?q?Usacw8TfS9WBQc6FCMek3UOgmxJi2KCDJB8hUYEgREIigwHAyg7ggmBMQMCi?=
 =?us-ascii?q?g4CggxhiACMYS4XhASNFB2ZN4YjkHKBcyONZ5U0hVoCBAIEBQIYNoEyggMMB?=
 =?us-ascii?q?3OBawmBQFADFwIPV41KDAsLHIRFji2/DHkCOwEBBwIHDAEBAwkCgVQUkDQug?=
 =
	?us-ascii?q?R4BAQ?=
X-Talos-CUID: 9a23:Cjz0rmM4j6/5Le5DSQA22mQUBuceUXzNxXL3OFaaJWN4cejA
X-Talos-MUID: =?us-ascii?q?9a23=3AOMYEug1bS4jJCflVvY+20/RSqTUj6qmfE3AgzZM?=
 =?us-ascii?q?6mdi4BBAuBBW4gTmOXdpy?=
X-IronPort-Anti-Spam-Filtered: true
X-IronPort-AV: E=Sophos;i="6.25,190,1779138000"; 
   d="jpg'145?scan'145,208,217,145";a="76213827"
X-Amp-Result: UNKNOWN
X-Amp-Original-Verdict: FILE UNKNOWN
X-Amp-File-Uploaded: False
X-MS-Has-Attach: yes
X-MS-TNEF-Correlator: 
X-MS-Exchange-Organization-ExpirationStartTime: 28 Jul 2026 10:07:45.6798
 (UTC)
X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit
X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000
X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit
X-MS-Exchange-Organization-Network-Message-Id: 1223659b-0c41-4797-2bab-08deec901221
X-EOPAttributedMessage: 0
X-EOPTenantAttributedMessage: 8fe098d2-428d-4bd4-9803-7195fe96f0e2:0
X-MS-Exchange-Organization-MessageDirectionality: Incoming
X-MS-PublicTrafficType: Email
X-MS-TrafficTypeDiagnostic: AMS1EPF0000004B:EE_|BESPR02MB12392:EE_|DB9PR02MB7817:EE_
X-MS-Exchange-Organization-AuthSource: AMS1EPF0000004B.eurprd04.prod.outlook.com
X-MS-Exchange-Organization-AuthAs: Anonymous
X-MS-Office365-Filtering-Correlation-Id: 1223659b-0c41-4797-2bab-08deec901221
X-MS-Exchange-AtpMessageProperties: SA|SL
X-MS-Exchange-Organization-SCL: -1
X-Microsoft-Antispam: BCL:0;ARA:13230040|704161711799003|82310400026|6049299003|12012899012|7149299003|13003099007|6133799003|4053099003|16102099003|55112099003|4076899003|11063799006|19002099009|56012099006|5063699009|18003699003|8096899003|10067099003;
X-Forefront-Antispam-Report: CIP:213.184.53.4;CTRY:EE;LANG:en;SCL:-1;SRV:;IPV:CAL;SFV:NSPM;H:mail1.rit.ee;PTR:mail1.rit.ee;CAT:NONE;SFS:(13230040)(704161711799003)(82310400026)(6049299003)(12012899012)(7149299003)(13003099007)(6133799003)(4053099003)(16102099003)(55112099003)(4076899003)(11063799006)(19002099009)(56012099006)(5063699009)(18003699003)(8096899003)(10067099003);DIR:INB;
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 28 Jul 2026 10:07:45.4978
 (UTC)
X-MS-Exchange-CrossTenant-Network-Message-Id: 1223659b-0c41-4797-2bab-08deec901221
X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2
X-MS-Exchange-CrossTenant-AuthSource: AMS1EPF0000004B.eurprd04.prod.outlook.com
X-MS-Exchange-CrossTenant-AuthAs: Anonymous
X-MS-Exchange-CrossTenant-FromEntityHeader: Internet
X-MS-Exchange-Transport-CrossTenantHeadersStamped: BESPR02MB12392
X-MS-Exchange-Transport-EndToEndLatency: 00:00:02.6385958
X-MS-Exchange-Processed-By-BccFoldering: 15.21.0245.008
X-MS-Exchange-ExternalInOutlookResult: NotEnabled
X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(930201)(20251009189)(140003);
X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?Rn+0S3DSHbhLIXMMWQobBbmJA8KWBP4DJZPjV/au3NjsIiYILVUAbeqSci4q?=
 =?us-ascii?Q?l4e/2VxrcC1a2eqCTmj/T9pmTgYcPMSD1yKzwFIbaNwSBe+mr/u8Vf5ZdZOH?=
 =?us-ascii?Q?fh289wGkLwGSeXvXlwZtN5Liy74WHyPA/SNT4fYr6E6gp1qHk8ALDEbSlx2v?=
 =?us-ascii?Q?tnET98jK/cebE8VqzorwksZU/8Ec32YmB2+vqGodOKA4qqkQMFEJL2q4Tr6h?=
 =?us-ascii?Q?SMBoZx3Rl2GR2SVtmCPeQ+esNTz5ZSqv6hFx8n+J+9ijTa4CBl6dY/9ESxsq?=
 =?us-ascii?Q?7PIhVFJ+qKMS16kFF8bh/ESYwqnto9PiQI0/5hVMPDk0oz2HwySOLwGQEcCK?=
 =?us-ascii?Q?+yPIv0f3TfaeoA2Q62rlzxHO60gRKAHTb9/cl5uGyFTQyD++FuKCKfQAwbZJ?=
 =?us-ascii?Q?Alfk9nrVWZLyxqTqe1l7BILCPnX/AJ9m27mj9bD+61IweeYmoH+7NIIkihON?=
 =?us-ascii?Q?hT4mCGWs82bBJb9uKz+NOmxwdy/HD7g+gfd0mHdLHrFL5M6WvdcpqSnLBAiI?=
 =?us-ascii?Q?Du0/LUD6ycBzZ8FyKWwBAJKSsxC3lA51PissaysVfwmdBRQCvbvUtxLh2hLe?=
 =?us-ascii?Q?yMKR8ly15jG3/J/LVnWHUVtmofYaA1X4jq8Y5m3LWrVRdiw/hbMvtdGPLSCh?=
 =?us-ascii?Q?az79LHhOpAlC4sNKqpJntRoBuuEZHMNlDpwH7fGVfeqWUbVTGDoSR/vVlZva?=
 =?us-ascii?Q?QnWvmP2Uz5zLwduUcm6oROs5BM+x3t/QitqzZbnzIbzSoEyOOuQ
	sL28mxWAp?=
 =?us-ascii?Q?r8PYGh8mGT1leSlOLsplcbPdaJ1UMx0alMRA2gKWjPqzHIhTHE3w26PE+dI0?=
 =?us-ascii?Q?lgpcUjY2r0rTu+uDgphMn6UUP1NkNKUBv0vLa16KSwVwnTqqLnoGgoIUfTz3?=
 =?us-ascii?Q?2t5R81rdnzro4nBRDzWkDPfPg4Ox4Jkdl8O9L+JHezcZvJbobtWRDZIVPw82?=
 =?us-ascii?Q?/gpAhXf9qx86qnDuZ/dKT/RDqrLiO948GFsyDLQ+05zrkWd0NYi4nzJtefgK?=
 =?us-ascii?Q?oNbl9iaZVpEt6o4td+CTESbp8BZ5VAYnx6ei9XSnFti+Dw8yxGHMRwBDXyuC?=
 =?us-ascii?Q?5wmB8yBCauLtU03LC4IxK6Gjv1mzLTLZD7mjvv5Z8cziGxeXQcUWFkV8OlW8?=
 =?us-ascii?Q?/tcLfdlxgGeOYv+2vkZiq9P9OzSF0ijbHLIfi7wJg0IrQAGkjKBqaOShyiBG?=
 =?us-ascii?Q?YmuNVIgqlvPAz5bMlewdxPBCv8ur5Z5ZgkHto2npI7a5AiB7rP7L5EIQ80ut?=
 =?us-ascii?Q?snoAQIB6BK7N23qEm446RRzf1TMLMipORltlUHgoXRSbpYEEdBjie09/dVRe?=
 =?us-ascii?Q?BxlQZoMZOFz1WYJ+pQ1pZqSzUHPR7GCPHiNoXzIqy+l5kQ3hhAKM3CtGMQvp?=
 =?us-ascii?Q?6WGaPREotoo/CLJ14MO5Gj3lBDi41WKNglcveAlqPIztQdQo4ZX6L73jIjLV?=
 =?us-ascii?Q?FcKHHy3bHWlre2yH4A+Qwzl3N4h5G/7hx9HGr40LwT2VZ8etQ+HosuSN7jIs?=
 =?us-ascii?Q?v2LkPckqrlIjXSJy080XRQL+VGCuq+aaDe1tZ
	xHXXVwxfOd5I0VUwJR+rkur?=
 =?us-ascii?Q?910it865M3eLsh3Fj6yWzzfYUf3sUW+Kb9RfjOlR+WRcuignNTEqfp4LJdsn?=
 =?us-ascii?Q?FHIDBbJiEXKomRXRfS5OR051ykcunLbrNASl5d6d96p+XHLK4fTYbgrcrBvM?=
 =?us-ascii?Q?Dp+t6fycK06ddxUMeGUZQdaF9bjGse7csxsFwGNmdAMigRzPaFN208YXNkG9?=
 =?us-ascii?Q?E4fBJzF2gvoqOQspehSXzmNwq/nzolAuqsnzaXmKgb/e5Wsau5IuhTwb1b3j?=
 =?us-ascii?Q?UqAqhydyUJyM9HwRdN3nQRZGN9nMP/iRGIYlug1JwIIOVIwW9hWc83sDvizu?=
 =?us-ascii?Q?p+paWVGS/Y8EZhO1pgl3EYEUzIzhmxS8Roe9hkk7WomVxy3qRjCerx1f4dcQ?=
 =?us-ascii?Q?mSDRPBF+xhp5UgaqyGy8RKaDjImbSJcJDwk9cCYzs6zygOz2y3txHvh2cDkB?=
 =?us-ascii?Q?4rG9MtPAtNhQ96/iB8MZX3kOtD9tBPl+BKRaAQYh/wLKNNj/sjUxIaiKlwF2?=
 =?us-ascii?Q?PFFCrubH6f2c/HgKWH5JnRMk1QX5svAE5cqAhGjq1eGIefty146yXKhiuL8u?=
 =?us-ascii?Q?68S61nJ6ZKEjPr72I4y6bOrwmD7CLL+KNMME0hjUya6MW5zSb40qWgAuvzwl?=
 =?us-ascii?Q?BD0ZXkjp5ZYmF9i3QCb7cxFALGRdcOSFVR8Mxchu+UOfGJahr9q8RX0PVo2d?=
 =?us-ascii?Q?Eua8JzWHrhy1aMpIKSoe48JSmY7kLDdafgATrAi5nr/wbL5Xqkf/hGIEi7hA?=
 =?us-ascii?Q?C6A7TSBX5j8wmML+mjT/X16
	9FcurWvj1TFqmN3M1Q12XnFLH0lweb57yaz8m?=
 =?us-ascii?Q?8IaYOrwXK7Ix8bA7ynbYRTuEleeoZ8rDTHvwqHGlspIx6wVbWC3rbu4GLY3W?=
 =?us-ascii?Q?zfh+CmrwkAUwVtw/iehN1U8Y3QiQKILgTNzBDrYcyb32xIzg8U9s6iBslaP4?=
 =?us-ascii?Q?o59fxLxvmkvrht66lBCYFFeezftYgv2BfqlevmiUumK5l8ODKk6n0Whusj6e?=
 =?us-ascii?Q?ZCqKRCmNNmD+LorA8DyKOrzM/BlPkOiT4PKe9JWVfm68IUS1pwtcSDrtfxnn?=
 =?us-ascii?Q?jqvIH048obs6aLHBTnPql/OSH/LnssLvUhl6imn+U6FOubs0hua3sUHiG/e1?=
 =?us-ascii?Q?X9y6QQ=3D=3D?=
Content-Language: en-us
x-ms-exchange-organization-originalclientipaddress: 213.184.53.4
x-ms-exchange-organization-originalserveripaddress: 10.167.16.136
acceptlanguage: en-GB, en-US
received-spf: Pass (mail1.rit.ee: domain of  postmaster@out.mail.ec.europa.eu designates 147.67.249.4 as  permitted sender) identity=helo; client-ip=147.67.249.4;  receiver=mail1.rit.ee;  envelope-from="SANTE-SOHO@ec.europa.eu";  x-sender="postmaster@out.mail.ec.europa.eu";  x-conformance=spf_only; x-record-type="v=spf1";  x-record-text="v=spf1 ip4:147.67.11.0/28 ip4:147.67.249.0/28  -all"
dkim-signature: v=1; a=rsa-sha256; c=relaxed/relaxed;    s=s2607; d=ec.europa.eu;    h=from:to:cc:subject:date:message-id:content-type:mime-version;    bh=aLU1r/KqLFMvs1xfLSza6m7610I9x9oFtcaMvB6FRlQ=;    b=aon+5qv7FLOskfjixlb4bpcuQZ4b1xl2uTZSRntb93auCDzNw8MhGg18lqr1F8      tYfmotig0UOChVwqIWeOY5CyuXMOzoPwcsINsLRSztOj5bSuECvMtDz1o1soPd      NIdwdk7ajCRza7Yg/3AV3wXLU29TcyQ8ue/Oebwswar9zyvfndnUPsNCOPu3MB      yrENAXGDcdKOgFTGHyZucRsRnXzXhD7d/u+KBQszrOQpxrwHCGN8Vty2CXRXEg      pUwqViUmJFKDsOnTT10BzVCJ0jjdUjNu4BoEhFnousWnl6hAMFEsVzR9EJmOpn      15u2MiMjb9Aou0O4ZD/XQuhczlnI59aw==
X-OlkEid: 00000000D07AAE8E23CDBE4CA04D01CCD82FCB7E070034AD76187591974DBF6C4F76951C873A01000200000000005797C783AAECB34FA6C879FF487E64D9000000000DFE000042F9122E4EEBFB46A6D1B63F1763EEB4
msip_labels: MSIP_Label_6bd9ddd1-4d20-43f6-abfa-fc3c07406f94_ActionId=d5eeb61c-9ca3-4c97-87f4-10c6b9b8fc9e;MSIP_Label_6bd9ddd1-4d20-43f6-abfa-fc3c07406f94_ContentBits=0;MSIP_Label_6bd9ddd1-4d20-43f6-abfa-fc3c07406f94_Enabled=true;MSIP_Label_6bd9ddd1-4d20-43f6-abfa-fc3c07406f94_Method=Privileged;MSIP_Label_6bd9ddd1-4d20-43f6-abfa-fc3c07406f94_Name=Commission Use;MSIP_Label_6bd9ddd1-4d20-43f6-abfa-fc3c07406f94_SetDate=2026-07-28T09:55:48Z;MSIP_Label_6bd9ddd1-4d20-43f6-abfa-fc3c07406f94_SiteId=b24c8b06-522c-46fe-9080-70926f8dddb1;MSIP_Label_6bd9ddd1-4d20-43f6-abfa-fc3c07406f94_Tag=10, 0, 1, 1;
x-originating-ip: [10.152.64.253]
X-DisclaimerOO: 1

This is a multipart message in MIME format.

------=_NextPart_000_0070_01DD1F5F.3D26F3A0
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_0071_01DD1F5F.3D2741C0"


------=_NextPart_001_0071_01DD1F5F.3D2741C0
Content-Type: text/plain;
	charset="utf-8"
Content-Transfer-Encoding: 8bit


Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.

> Competent Authorities for blood and blood components, Competent 
> Authorities for tissues and cells
cc: SCB Members and Alternates

Dear colleagues,



As part of the revision of the Standard Operating Procedure for the Rapid 
Alerts for Blood and blood components (RAB) and the Rapid Alerts for Tissues 
and Cells (RATC), particularly in relation to epidemiological notices, the 
RAB/RATC subgroup of the Vigilance and Traceability Working Group of the SCB 
has prepared a survey, available here: 
<https://ec.europa.eu/eusurvey/runner/Epidemiological_notices_RAB_RATC_Survey> 
https://ec.europa.eu/eusurvey/runner/Epidemiological_notices_RAB_RATC_Survey 
.



The aim of this EU survey is to gather your views and practical experience 
regarding the use of epidemiological notices on the Rapid Alert for Blood 
(RAB) and Rapid Alert for Tissues and Cells (RATC) platforms in your Member 
State.



The survey should be completed by Competent Authorities or organisations 
that, at the time of reply, have access to the RAB and/or RATC platform, in 
line with their current use of these platforms.
One or more responses may be submitted per Member State, depending on the 
number of Competent Authorities in your country.

If you are not the Competent Authority or organisation that, at the time of 
reply, has access to the RAB and/or RATC platform, please forward this 
survey to the body or bodies responsible for RAB/RATC in your Member State.



The survey will remain open until Friday 28 August 2026.



Should you have any questions concerning the survey, please contact 
SANTE-SOHO@ec.europa.eu <mailto:SANTE-SOHO@ec.europa.eu> .



We thank you in advance for your cooperation.



Kind regards,




MIRKO CLAUS

Policy Officer, on behalf of the SoHO team

---




European Commission
DG SANTE (Health and Food Safety)

Unit D2 – Medical Products: quality, safety, innovation

Office address: Rue Breydel 2, 06/004, B-1049 Brussels/Belgium
 <https://health.ec.europa.eu/blood-tissues-cells-and-organs_en> 
https://health.ec.europa.eu/blood-tissues-cells-and-organs_en


------=_NextPart_001_0071_01DD1F5F.3D2741C0
Content-Type: text/html;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:o=3D"urn:schemas-microsoft-com:office:office" =
xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:x=3D"urn:schemas-microsoft-com:office:excel" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" =
xmlns=3D"http://www.w3.org/TR/REC-html40"><head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; =
charset=3Dutf-8">
<meta name=3D"Generator" content=3D"Microsoft Word 15 (filtered =
medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Aptos;
	panose-1:2 11 0 4 2 2 2 2 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0cm;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:#467886;
	text-decoration:underline;}
span.EmailStyle17
	{mso-style-type:personal-compose;
	font-family:"Aptos",sans-serif;
	color:windowtext;}
span.TmpSel520aecea38cc4cd99d5161ba1af65004
	{mso-style-name:tmpsel520aecea38cc4cd99d5161ba1af65004;}
.MsoChpDefault
	{mso-style-type:export-only;
	font-size:11.0pt;
	mso-ligatures:none;
	mso-fareast-language:EN-US;}
@page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]-->
</head>
<body link=3D"#467886" vlink=3D"#96607D" style=3D"word-wrap:break-word">
<table class=3D"MsoNormalTable" border=3D"0" cellspacing=3D"0" =
cellpadding=3D"0" align=3D"left" width=3D"100%" =
style=3D"width:100.0%;mso-cellspacing:0cm;mso-yfti-tbllook:1184; =
mso-table-lspace:2.25pt;mso-table-rspace:2.25pt;mso-table-anchor-vertical=
:paragraph;mso-table-anchor-horizontal:column;mso-table-left:left;mso-pad=
ding-alt:0cm 0cm 0cm 0cm">
<tbody>
<tr =
style=3D"mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes">
<td style=3D"background:#910A19;padding:5.25pt 1.5pt 5.25pt 1.5pt"></td>
<td width=3D"100%" =
style=3D"width:100.0%;background:#FDF2F4;padding:5.25pt 3.75pt 5.25pt =
11.25pt; word-wrap:break-word" cellpadding=3D"7px 5px 7px 15px" =
color=3D"#212121">
<div>
<p class=3D"MsoNormal" =
style=3D"mso-element:frame;mso-element-frame-hspace:2.25pt; =
mso-element-wrap:around;mso-element-anchor-vertical:paragraph;mso-element=
-anchor-horizontal: column;mso-height-rule:exactly">
<span style=3D"font-size:9.0pt;font-family: &quot;Segoe =
UI&quot;,sans-serif;mso-fareast-font-family:&quot;Times New =
Roman&quot;;color:#212121"><strong>T=C3=A4helepanu!
</strong>Tegemist on v=C3=A4lisv=C3=B5rgust saabunud kirjaga.<br>
Tundmatu saatja korral palume linke ja faile mitte =
avada.<o:p></o:p></span></p>
</div>
</td>
</tr>
</tbody>
</table>
<div>
<div class=3D"WordSection1">
<p class=3D"MsoNormal"><span lang=3D"EN-IE">&gt; Competent Authorities =
for blood and blood components, Competent Authorities for tissues and =
cells<br>
cc: SCB Members and Alternates<br>
</span><span lang=3D"EN-IE"><br>
<span class=3D"TmpSel520aecea38cc4cd99d5161ba1af65004">Dear =
colleagues,<o:p></o:p></span></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-IE"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-IE">As part of the revision of =
the Standard Operating Procedure for the Rapid Alerts for Blood and =
blood components (RAB) and the Rapid Alerts for Tissues and Cells =
(RATC), particularly in relation to
<b>epidemiological notices,</b> the RAB/RATC subgroup of the Vigilance =
and Traceability Working Group of the SCB has prepared a
<b>survey, </b>available <b>here</b>: <a =
href=3D"https://ec.europa.eu/eusurvey/runner/Epidemiological_notices_RAB_=
RATC_Survey">
https://ec.europa.eu/eusurvey/runner/Epidemiological_notices_RAB_RATC_Sur=
vey</a> .<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span =
lang=3D"EN-IE">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;
<o:p></o:p></span></p>
<p class=3D"MsoNormal">The aim of this EU survey is to gather your views =
and practical experience regarding the use of
<b>epidemiological notices</b> on the <b>Rapid Alert for Blood (RAB) =
</b>and<b> Rapid Alert for Tissues and Cells (RATC)</b> platforms in =
your Member State.<span lang=3D"EN-GB"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-GB"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-IE">The survey should be =
completed <b>by Competent Authorities</b> or
<b>organisations</b> that, at the time of reply, <b>have access to the =
RAB and/or RATC platform</b>, in line with their current use of these =
platforms.
<br>
One or more responses may be submitted per Member State, depending on =
the number of Competent Authorities in your =
country.<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-IE">If you are not the Competent =
Authority or organisation that, at the time of reply, has access to the =
RAB and/or RATC platform, please forward this survey to the body or =
bodies responsible for RAB/RATC in your Member =
State.<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-IE"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-IE">The survey will remain open =
until <b>Friday 28 August 2026.</b><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-IE"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-IE">Should you have any =
questions concerning the survey, please contact &nbsp;<a =
href=3D"mailto:SANTE-SOHO@ec.europa.eu">SANTE-SOHO@ec.europa.eu</a>.<o:p>=
</o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-IE"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-IE">We thank you in advance for =
your cooperation.<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-IE">&nbsp;<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-IE">Kind regards,<br>
<br>
<br>
<o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span lang=3D"EN-GB" =
style=3D"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-lig=
atures:standardcontextual;mso-fareast-language:#1000">MIRKO =
CLAUS</span></b><span lang=3D"EN-IE"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-GB" =
style=3D"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-lig=
atures:standardcontextual;mso-fareast-language:#1000">Policy Officer, on =
behalf of the SoHO team</span><span =
lang=3D"EN-IE"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-IE" =
style=3D"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-li=
gatures:standardcontextual;mso-fareast-language:#1000">---<br>
</span><span lang=3D"EN-US" =
style=3D"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-li=
gatures:standardcontextual;mso-fareast-language:EN-IE">&nbsp;</span><span=
 lang=3D"EN-IE"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"FR-BE" =
style=3D"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;color:=
#1F497D;mso-fareast-language:EN-IE"><img border=3D"0" width=3D"98" =
height=3D"48" style=3D"width:1.0166in;height:.5in" =
id=3D"Picture_x0020_2" =
src=3D"cid:image001.jpg@01DD1E87.9D386540"></span><span =
lang=3D"EN-IE"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span lang=3D"FI" =
style=3D"font-size:8.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#=
1F497D;mso-ligatures:standardcontextual;mso-fareast-language:EN-IE">Europ=
ean Commission</span></b><span lang=3D"FI" =
style=3D"font-size:8.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#=
1F497D;mso-ligatures:standardcontextual;mso-fareast-language:EN-IE">
<br>
DG SANTE (Health and Food Safety)</span><span =
lang=3D"EN-IE"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"FI" =
style=3D"font-size:8.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#=
1F497D;mso-ligatures:standardcontextual;mso-fareast-language:EN-IE">Unit =
D2 =E2=80=93 Medical Products: quality, safety, innovation<br>
<br>
Office address: Rue Breydel 2, 06/004, B-1049 Brussels/Belgium <br>
</span><span lang=3D"EN-GB" =
style=3D"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-li=
gatures:standardcontextual;mso-fareast-language:EN-IE"><a =
href=3D"https://health.ec.europa.eu/blood-tissues-cells-and-organs_en"><s=
pan lang=3D"FI" =
style=3D"font-size:8.0pt;color:blue">https://health.ec.europa.eu/blood-ti=
ssues-cells-and-organs_en</span></a></span><span =
lang=3D"EN-IE"><o:p></o:p></span></p>
</div>
</div>
</body>
</html>

------=_NextPart_001_0071_01DD1F5F.3D2741C0--

------=_NextPart_000_0070_01DD1F5F.3D26F3A0
Content-Type: image/jpeg;
	name="image001.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image001.jpg@01DD1E87.9D386540>
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=

------=_NextPart_000_0070_01DD1F5F.3D26F3A0--
